HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frits van Rhee Selected Research

ixazomib

4/2024Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study.
7/2021Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frits van Rhee Research Topics

Disease

73Multiple Myeloma
04/2024 - 01/2003
24Neoplasms (Cancer)
10/2023 - 05/2005
22Castleman Disease (Castleman's Disease)
02/2024 - 07/2010
12Chromosome Aberrations (Chromosome Abnormalities)
01/2024 - 04/2006
10Edema (Dropsy)
02/2024 - 04/2016
10Thrombocytopenia (Thrombopenia)
02/2024 - 03/2017
9Fever (Fevers)
02/2024 - 07/2013
7Inflammation (Inflammations)
01/2022 - 01/2019
7Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022 - 08/2010
7Disease Progression
02/2021 - 03/2006
6Multi-centric Castleman's Disease
08/2022 - 05/2014
5Fibrosis (Cirrhosis)
02/2024 - 01/2018
5Bone Diseases (Bone Disease)
10/2023 - 09/2009
5Cytokine Release Syndrome
01/2022 - 05/2014
4Lymphadenopathy
02/2024 - 04/2016
4Anemia
02/2024 - 10/2015
3Infections
03/2024 - 10/2015
3Renal Insufficiency (Renal Failure)
11/2023 - 10/2021
3Primary Myelofibrosis (Myelosclerosis)
01/2022 - 01/2019
3Smoldering Multiple Myeloma
02/2021 - 10/2008
3Fatigue
03/2020 - 07/2013
2Neutropenia
07/2023 - 03/2020
2Paraproteinemias (Monoclonal Gammopathy)
11/2022 - 09/2006
2Hypoalbuminemia
01/2022 - 03/2017
2Genetic Translocation (Chromosomal Translocation)
01/2022 - 07/2014
2Thrombocytosis (Thrombocythemia)
01/2022 - 03/2017
2Cytopenia
01/2019 - 03/2017
2Hematologic Neoplasms (Hematological Malignancy)
11/2018 - 02/2016
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2013 - 01/2008
2Leukemia
06/2013 - 08/2012
2Testicular Neoplasms (Testicular Cancer)
05/2011 - 11/2007
1Hyperferritinemia
03/2024
1Immunoglobulin G4-Related Disease
02/2024
1Agammaglobulinemia (Hypogammaglobulinemia)
07/2023
1Residual Neoplasm
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1COVID-19
01/2022
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022
1Communicable Diseases (Infectious Diseases)
10/2021
1Ehrlichiosis
08/2021
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
08/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Nausea
03/2020

Drug/Important Bio-Agent (IBA)

16Interleukin-6 (Interleukin 6)IBA
01/2022 - 08/2010
13Monoclonal AntibodiesIBA
01/2022 - 09/2009
13siltuximabIBA
01/2022 - 08/2010
12Thalidomide (Thalomid)FDA Link
12/2023 - 07/2003
10Bortezomib (Velcade)FDA Link
12/2023 - 07/2007
8Reticulin (Reticular Fiber)IBA
02/2024 - 01/2018
7Melphalan (Alkeran)FDA LinkGeneric
12/2023 - 03/2006
7CytokinesIBA
01/2022 - 05/2014
7C-Reactive ProteinIBA
01/2022 - 10/2006
5Lenalidomide (CC 5013)FDA Link
04/2024 - 08/2012
5Chimeric Antigen ReceptorsIBA
02/2024 - 01/2022
5bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
02/2024 - 01/2023
5Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2007
4Dexamethasone (Maxidex)FDA LinkGeneric
04/2024 - 08/2010
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2024 - 10/2006
4Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2007
4daratumumabIBA
08/2021 - 01/2018
4elotuzumabIBA
06/2014 - 05/2008
4AntigensIBA
05/2011 - 05/2005
3Proteasome InhibitorsIBA
04/2024 - 02/2008
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2019
3Messenger RNA (mRNA)IBA
04/2010 - 09/2006
2ixazomibIBA
04/2024 - 07/2021
2Intravenous Immunoglobulins (IVIG)FDA Link
03/2024 - 07/2023
2Immunoglobulin G (IgG)IBA
02/2024 - 01/2022
2Hemoglobins (Hemoglobin)IBA
02/2024 - 07/2013
2Bispecific AntibodiesIBA
07/2023 - 01/2022
2Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2018
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 06/2013
2Phosphotransferases (Kinase)IBA
01/2020 - 11/2018
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2016 - 01/2016
2InterleukinsIBA
10/2015 - 08/2014
2VaccinesIBA
09/2010 - 11/2005
1Transferrin (beta 2 Transferrin)IBA
03/2024
1B-Cell Maturation AntigenIBA
01/2024
1Cisplatin (Platino)FDA LinkGeneric
12/2023
1Etoposide (VP 16)FDA LinkGeneric
12/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2023
1Cystatin MIBA
10/2023
1NIMA-Related KinasesIBA
10/2023
1ChromatinIBA
10/2022
1tocilizumab (atlizumab)FDA Link
01/2022
1SteroidsIBA
01/2022
1tisagenlecleucelIBA
01/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2021
1Cell-Free Nucleic AcidsIBA
02/2021

Therapy/Procedure

49Therapeutics
02/2024 - 07/2003
9Drug Therapy (Chemotherapy)
11/2023 - 07/2003
7Stem Cell Transplantation
03/2022 - 09/2006
7Immunotherapy
04/2017 - 05/2005
5Transplantation
01/2022 - 04/2006
4Autologous Transplantation
03/2010 - 08/2007
3Hematopoietic Stem Cell Transplantation
12/2023 - 03/2006
2Homologous Transplantation
05/2006 - 01/2003
1Aftercare (After-Treatment)
01/2022
1Maintenance Chemotherapy
08/2021